- Home
- DBVT vs AFRI Comparison
DBVT vs AFRI Comparison
Compare DBVT & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- AFRI
- Stock Information
- Founded
- DBVT 2002
- AFRI 1943
- Country
- DBVT France
- AFRI Gibraltar
- Employees
- DBVT N/A
- AFRI N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- AFRI Packaged Foods
- Sector
- DBVT Health Care
- AFRI Consumer Staples
- Exchange
- DBVT Nasdaq
- AFRI Nasdaq
- Market Cap
- DBVT 239.9M
- AFRI 214.9M
- IPO Year
- DBVT N/A
- AFRI N/A
- Fundamental
- Price
- DBVT $8.35
- AFRI $7.78
- Analyst Decision
- DBVT Buy
- AFRI
- Analyst Count
- DBVT 4
- AFRI 0
- Target Price
- DBVT $14.81
- AFRI N/A
- AVG Volume (30 Days)
- DBVT 102.2K
- AFRI 20.6K
- Earning Date
- DBVT 07-29-2025
- AFRI 06-10-2025
- Dividend Yield
- DBVT N/A
- AFRI N/A
- EPS Growth
- DBVT N/A
- AFRI N/A
- EPS
- DBVT N/A
- AFRI N/A
- Revenue
- DBVT $3,497,000.00
- AFRI $274,223,000.00
- Revenue This Year
- DBVT $1,700.53
- AFRI N/A
- Revenue Next Year
- DBVT $535.67
- AFRI N/A
- P/E Ratio
- DBVT N/A
- AFRI N/A
- Revenue Growth
- DBVT N/A
- AFRI N/A
- 52 Week Low
- DBVT $2.21
- AFRI $7.54
- 52 Week High
- DBVT $12.78
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- DBVT 42.98
- AFRI 34.98
- Support Level
- DBVT $8.33
- AFRI $7.62
- Resistance Level
- DBVT $9.92
- AFRI $7.89
- Average True Range (ATR)
- DBVT 0.92
- AFRI 0.17
- MACD
- DBVT -0.32
- AFRI 0.03
- Stochastic Oscillator
- DBVT 4.53
- AFRI 49.50
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.